Endo Sues Mylan Over Generic Lidoderm Patch

Law360, New York (March 16, 2011, 2:19 PM EDT) -- Endo Pharmaceuticals Inc. sued Mylan Pharmaceuticals Inc. in Delaware federal court Monday, asking the court to block a generic version of Endo's Lidoderm patch that might infringe a patent for topical medication patches.

Mylan sent Endo a letter in January announcing that it was filing an abbreviated new drug application for a generic version of Lidoderm with the U.S. Food and Drug Administration, according to a complaint filed in the U.S. District Court for the District of Delaware.

The letter said the proposed generic lidocaine patch...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.